Primary care-based ambulatory opioid detoxification (original) (raw)

Abstract

OBJECTIVE: To determine the feasibility of primary care-based ambulatory opioid detoxification (AOD) using two protocols: clonidine and clonidine plus naltrexone.

SETTING: The Central Medical Unit (CMU)—a freestanding primary care medical clinic staffed by physicians and nurse practitioners.

PATIENTS: Injection drug users (IDUs) seeking substance abuse treatment between the ages of 18 and 50 years who were addicted to opioids (e.g., heroin) and not currently in drug treatment.

INTERVENTIONS: In the clonidine protocol, clonidine was administered every 4 hours “as needed” for up to 12 days. In the clonidine plus naltrexone protocol, clonidine was administered and naltrexone was administered in increasing doses over five days. Both protocols included “adjuvant” medications for muscle cramps, insomnia, and vomiting. Successfully detoxified patients were referred to ongoing drug treatment.

DESIGN: A prospective nonrandomized clinical trial.

MEASUREMENTS AND MAIN RESULTS: One hundred forty opioid-addicted IDUs were referred to the medical clinic for AOD. Among the 125 patients who enrolled in the study, 57 selected clonidine and 68 selected clonidine/naltrexone. The treatment groups (clonidine vs clonidine/naltrexone) were similar at baseline with respect to: age at first heroin use (21 years vs 23 years), mean admission opioid craving score (45/100 vs 49/100), and withdrawal symptom score (19/72 vs 18/72). Overall, 70% (88/125) of the AODs were successful, including 42% (24/57) for clonidine and 94% (64/68) for clonidine/naltrexone (p<0.001).

CONCLUSIONS: This study suggests that primary care-based AOD can be safely and effectively carried out by primary care providers and that clonidine/naltrexone may be more effective in this setting than is clonidine alone. Ambulatory opioid detoxification can give internists a larger role in initiating drug treatment for IDUs who are addicted to opioids.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O’Connor PG, Selwyn PA, Schottenfeld RS. Medical progress: medical care for injection drug users with human immunodeficiency virus infection. N Engl J Med. 1994;331:450–9.
    Article PubMed Google Scholar
  2. Stein MD. Medical complications of intravenous drug use. J Gen Intern Med. 1990;5:249–57.
    Article CAS PubMed Google Scholar
  3. Kamerow DB, Pincus HA, Macdonald DI. Alcohol abuse, other drug abuse, and mental disorders in medical practice: prevalence, costs, recognition, and treatment. JAMA. 1986;255:2054–7.
    Article CAS PubMed Google Scholar
  4. Methadone: rule and regulations. Federal Register. 1989;54:8954.
  5. Newman RG. Methadone treatment. Defining and evaluating success. N Engl J Med. 1987;317:447–9.
    Article CAS PubMed Google Scholar
  6. O’Connor PG, Waugh ME, Schottenfeld RS, Diagkogiannis IA, Rounsaville BJ. Ambulatory opiate detoxification and primary care: a role for the primary care physician. J Gen Intern Med. 1992;7:532–4.
    Article PubMed Google Scholar
  7. Charney DS, Sternberg DE, Kleber HD, et al. The clinical use of clonidine in abrupt withdrawal from methadone. Arch Gen Psychiatry. 1981;38:1273–7.
    Article CAS PubMed Google Scholar
  8. Jasinski DR, Johnson RF, Kocher TR. Clonidine in morphine withdrawal. Arch Gen Psychiatry. 1985;42:1063–6.
    Article CAS PubMed Google Scholar
  9. Riordan CE, Kleber HD. Rapid opiate detoxification with clonidine and naltrexone. Lancet. 1980;1:1079–80.
    Article CAS PubMed Google Scholar
  10. Charney DS, Heninger GR, Kleber HD. The combined use of clonidine and naltrexone as rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry. 1986;143:831–7.
    Article CAS PubMed Google Scholar
  11. Washton AM. Clonidine for opiate detoxification: outpatient clinical trial. Am J Psychiatry. 1980;130:1121–2.
    Google Scholar
  12. Kleber HD, Topazian M, Gaspari J, Riordan CE, Kosten T. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse. 1987;12:1–17.
    Article Google Scholar
  13. Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict. 1988;83:567–75.
    Article CAS PubMed Google Scholar
  14. O’Connor PG, Molde S, Henry S, Shockor WT, Schottenfeld RS. Human immunodeficiency virus infection in intravenous drug users: a model for primary care. Am J Med. 1992;93:382–6.
    Article PubMed Google Scholar
  15. Pressley R. Outreach interventions with intravenous drug users (IVDUs) and sexual partners (SPs): seven varied approaches to outreach. Bethesda, MD: Second Annual National AIDS Demonstration Research (NADR) National Meeting, 1990.
  16. Kosten TR, Rounsaville BJ, Kleber HD. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse. 1985;11:1–10.
    Article CAS PubMed Google Scholar
  17. Horwitz RI, Gottlieb LD, Kraus ML. The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch Intern Med. 1989;149:1089–93.
    Article CAS PubMed Google Scholar
  18. Schuckit MA. Opiates and other analgesics. In: Drug and Alcohol Abuse. A Clinical Guide to Diagnosis and Treatment, Third Edition. New York: Plenum Publishing, 1989:118–42.
    Google Scholar
  19. Martin WT, Jasinski DR. Physiological parameters of morphine dependence on man: tolerance, early abstinence, protracted abstinence. J Psychiatr Res. 1969;7:9–17.
    Article CAS PubMed Google Scholar
  20. Group for the Advancement of Psychiatry. Committee on Alcoholism and the Addictions. Substance abuse disorders: a psychiatric priority. Am J Psychiatry. 1991;148:1291–300.
    Article Google Scholar
  21. Brewer C, Mathew KI. Naloxone and opiate addiction. Lancet. 1989;11:683–4.
    Article Google Scholar

Download references

Author information

Authors and Affiliations

  1. the Department of Medicine, Yale University School of Medicine, New Haven, Connecticut
    Patrick G. O’Connor MD, MPH
  2. Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
    Martin E. Waugh DO, Kathleen M. Carroll PhD, Bruce J. Rounsaville MD, Ioannis A. Diagkogiannis MD & Richard S. Schottenfeld MD

Authors

  1. Patrick G. O’Connor MD, MPH
    You can also search for this author inPubMed Google Scholar
  2. Martin E. Waugh DO
    You can also search for this author inPubMed Google Scholar
  3. Kathleen M. Carroll PhD
    You can also search for this author inPubMed Google Scholar
  4. Bruce J. Rounsaville MD
    You can also search for this author inPubMed Google Scholar
  5. Ioannis A. Diagkogiannis MD
    You can also search for this author inPubMed Google Scholar
  6. Richard S. Schottenfeld MD
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

O’Connor, P.G., Waugh, M.E., Carroll, K.M. et al. Primary care-based ambulatory opioid detoxification.J Gen Intern Med 10, 255–260 (1995). https://doi.org/10.1007/BF02599882

Download citation

Key words